biotechnology Articles - Perficient Blogs
Blog

Posts Tagged ‘biotechnology’

  • Topics
  • Industries
  • Partners

Explore

Topics

Industries

Partners

How To Determine Whether Your IT System Is Regulated

A couple weeks back, I launched a brief blog series about assessing and mitigating risk with regulated IT systems. This week’s post will cover the first part in a four-part approach you can use to do just that: assess and mitigate risk. Part One: System Regulated Status The first step is to determine whether a […]

Read more

Obamacare Repeal Could Fuel Pharma And Biotech Acquisitions

Just last week, the house voted to repeal Obamacare, and much has already been covered in articles readily available on the internet. But the Senate has already stated they will write up new legislation that will take into consideration the House bill. No timeline for the Senate to produce its new legislation has been set, […]

Read more

It’s Official: Dr. Scott Gottlieb To Lead FDA

One of the key issues and perspectives we outlined in our recent State of the Life Sciences Industry guide was President Trump’s intention to reform the Food and Drug Administration (FDA) through the elimination or significant modification of regulations. Part of his recipe for reforming the FDA included bringing in a new head of the […]

Read more

Happy May Day! Top 5 Life Sciences Blog Posts From April 2017

Happy May Day! Now that May is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in April – they’re ranked in order of popularity, with number one being the most viewed piece. My Colleagues […]

Read more

[Webinar] Upgrading Siebel Clinical To IP2016 & Preview Of IP2017

Because Siebel Innovation Pack (IP) 2016 was such a significant departure from previous Siebel versions, our clinical operations team devoted much of last year to beta testing it, helping Oracle identify and iron out the kinks. Now that we have finished our assessment of the risks and rewards of upgrading Siebel Clinical to IP2016, we […]

Read more

New Guide On Modernizing Clinical Trials With Digital Experiences

The industry is all a-buzz with digital engagement initiatives for patients, but let’s not forget about clinical subjects and even site personnel. They’re technology consumers, just like the rest of us, and they crave clinical trials that are simple, easy, convenient, and engaging. As an advocate for sites and subjects, Perficient just published a guide […]

Read more

Duke & FDA Study On Investigator Retention Shows 54% Turnover

Last month, Duke University and the FDA released the results of a jointly conducted study on principal investigator (PI) retention. The study was released early online, but the print version is being published in June in the journal of Contemporary Clinical Trials Communications, published by Elsevier. The purpose of the study was two-fold: 1) to […]

Read more

[Guide] The State Of The Life Sciences Industry

Last year’s presidential election invoked a great deal of angst in the pharmaceutical industry, with the cost of drugs taking center stage for a good portion of some candidates’ campaigns. While the things candidates said they would do could very well be different from what they might actually do, their words and records were enough […]

Read more

Fortune’s 6 Best Life Sciences Companies To Work For

Fortune just released their list of the 100 best companies to work for in America. The survey, which was compiled by Great Places to Work, generated feedback from over 230,000 individuals. The data collected and analyzed took into consideration a variety of aspects that have the potential to influence people’s feelings towards their workplace, including […]

Read more

The Trump Administration’s Impact On Pharma

There are plenty of articles out there about how the pharmaceutical industry may be affected by Donald Trump’s presidency. The problem is that nobody exactly knows how things are going to pan out over the next few years. When it comes to health insurance, the price of drugs, and the quality of providers across the entire health […]

Read more

Asset Management In Life Sciences

My colleague, Chris Bangma, published a blog post last week that touches on how IBM Maximo, a comprehensive asset management system for managing physical assets, can comply with the FDA’s 21 CFR Part 11 regulation. In particular, he highlights three key areas of the rule that governs the use of electronic records and electronic signatures […]

Read more

Digital Technology In The Subject Screening Process

Subject screening adds significant cost to a trial, so it’s an ideal process to try to streamline. Subjects who don’t meet eligibility requirements ultimately lower the efficiency and ROI of a trial, since time and money was spent on those assessments. The screening process is one area that presents an opportunity for cost-savings, whether it […]

Read more

How Pokémon Go Relates To Life Sciences And Healthcare

Pokémon Go is an example of a mobile app that is experiencing wild success. The global phenomenon, which is now estimated to generate over one million dollars in revenue every day, is making experts in all industries ask, “How can I achieve similar success?” Personally, I think the success of Pokémon Go can be attributed […]

Read more

Top 5 Life Sciences Blog Posts From May 2016

Now that June is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in May – they’re ranked in order of popularity, with number one being the most viewed piece. Gartner’s List Of 5 Cool Vendors […]

Read more

13 Facts To Celebrate Genentech’s 40th Birthday

I came across an article that celebrated Genentech’s 40 years in business with a few fun facts and stories about the biotechnology pioneer: Founded on April 7, 1976 The name Genentech stems from GENetic ENgineering TECHnology The company was founded with a $1,000 investment in 1976 by Robert Swanson, a venture capitalist, and Herbert Boyer, […]

Read more

When TV Host John Stossel Says Your Customer Service “Stinks”

John Stossel, the host of a Fox News weekly program that highlights current consumer issues, was recently diagnosed with lung cancer. The good news is that it was caught early. It wasn’t his diagnosis that went viral, but rather the article he wrote from his hospital bed. “I have to say, the hospital’s customer service […]

Read more

Gartner’s List Of 5 Cool Vendors In Life Sciences

If there’s one list that gets a lot of touch attention in life sciences, it’s Gartner’s Cool Vendors in Life Sciences. While the name of the list helps grab attention on its own, the companies it features are typically just as interesting. This year’s list happens to carry a few companies that we’ve blogged about, […]

Read more

FDA Director: We’re Watching How You Manage Product Complaints

We frequently blog about FDA Warning Letters and other regulatory and compliance issues that revolve around traditional pharmaceuticals and medical devices. However, one product segment that we haven’t yet discussed is digital health. This is because digital health products are fairly new to the market and most are still trying to figure out how FDA […]

Read more

Keeping Data Secure In Life Sciences

In 2015, companies in all industries experienced data security breaches. From Anthem, one of the nation’s leading health benefits companies, to the UCLA Health System, all the way to Hzone, a matchmaking mobile application for HIV positive singles, no company was safe from a data breach. Increasing data privacy and security is a trend that […]

Read more

Transparency In Clinical Trials And Operations

  Demographics in clinical trials have always been scrutinized by the medical community and the public. Are various races, ethnicities, sexes, and ages fairly represented in trials? Does one segment respond better or worse than another to a particular treatment? These questions and more are being answered in the Drug Trials Snapshots section of the […]

Read more

Subscribe to the Weekly Blog Digest:

Sign Up